Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00402181
What this trial is testing

An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centocor, Inc. 53
Early research (Phase 1)Study completedNCT00972712
What this trial is testing

Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748689
What this trial is testing

Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Relapsed / Refractory Multiple Myeloma
Polish Myeloma Consortium 228
Testing effectiveness (Phase 2)Study completedNCT00086216
What this trial is testing

Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Callisto Pharmaceuticals 30
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT01042704
What this trial is testing

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

Who this might be right for
Myeloma
Robert Redner, MD 29
Not applicableLooking for participantsNCT07609030
What this trial is testing

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Multiple MyelomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more
Ohio State University Comprehensive Cancer Center 90
Very early researchLooking for participantsNCT04603872
What this trial is testing

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, RefractoryAcute Lymphoblastic Leukemia, in Relapse+3 more
Zhejiang University 120
Early research (Phase 1)Study completedNCT01549431
What this trial is testing

Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 32
Very early researchNot Yet RecruitingNCT06359509
What this trial is testing

Study of SYS6020 in BCMA-positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Testing effectiveness (Phase 2)Looking for participantsNCT07096778
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06282978
What this trial is testing

Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes

Who this might be right for
Multiple Myeloma in Relapse
PETHEMA Foundation 50
Testing effectiveness (Phase 2)Ended earlyNCT03492138
What this trial is testing

Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ajai Chari 5
Large-scale testing (Phase 3)Study completedNCT00179647
What this trial is testing

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene Corporation 1,913
Testing effectiveness (Phase 2)Study completedNCT00004902
What this trial is testing

Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Early research (Phase 1)Ended earlyNCT04244656
What this trial is testing

A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
CRISPR Therapeutics AG 26
Testing effectiveness (Phase 2)Ended earlyNCT00241371
What this trial is testing

A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 8
Early research (Phase 1)Looking for participantsNCT05913804
What this trial is testing

YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850599
What this trial is testing

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
OHSU Knight Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT01045681
What this trial is testing

Study of Bendamustine, Velcade and Dexamethasone in the Treatment of Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 75
Next Page